ICARES Medicus, Inc. (TPEX: 6612)

Market Cap	4.96B
Revenue (ttm)	742.27M
Net Income (ttm)	66.08M
Shares Out	42.57M
EPS (ttm)	1.55
PE Ratio	75.30
Forward PE	n/a
Dividend	0.18 (0.16%)
Ex-Dividend Date	Jul 8, 2024

Volume	18,508
Open	116.50
Previous Close	118.00
Day's Range	116.50 - 116.50
52-Week Range	96.36 - 177.00
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 14, 2025

About ICARES Medicus

ICARES Medicus, Inc., a nano-medical material company, focuses on the research and development, manufacture, and sale of ophthalmic medical materials in Taiwan and internationally. It provides ophthalmic medical materials, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, or astigmatism; and surgical implantation systems, as well as related technical services. ICARES Medicus, Inc. was incorporated in 2011 and is based in Zhubei, Taiwan.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2023, ICARES Medicus's revenue was 605.45 million, an increase of 18.29% compared to the previous year's 511.85 million. Earnings were 97.73 million, a decrease of -24.19%.